Farsalinos

Malaysia Nicotine Poison Mess

Sun, 06 Sep 2026 00:00:00 +0000

Key Takeaways
#

Malaysia’s High Court ruled in May 2026 that a 2023 order exempting liquid and gel nicotine from the Poisons List was unlawful.
The government dropped its appeal in August 2026, letting that ruling stand.
Nicotine e-liquid is now a Group C poison — only pharmacists or doctors can dispense it. Analysts call this a de facto ban.
A separate law, the Control of Smoking Products for Public Health Act 2024, still regulates vape sales. Two laws now pull in opposite directions.
Over RM354 million (roughly $88.5 million) in excise duties collected since 2023 sit at the center of a growing refund dispute.

What Is the Current Legal Status of Nicotine Vape in Malaysia?
#

Right now, nicotine e-liquid is a Group C poison under the Poisons Act 1952. That means only a licensed pharmacist or registered doctor can legally dispense it — not a vape shop, not an online store. Only two nicotine products are exempt: tobacco itself, and registered nicotine patches or gum for smoking cessation.

SRNT Recommendations to US Physicians on Nicotine E-Cigarettes

Wed, 02 Sep 2026 00:00:00 +0000

The international Society for Research on Nicotine and Tobacco (SRNT) recently published in JAMA its recommendations for U.S. clinicians on e-cigarettes and smoking cessation. Here, I examine the scientific, clinical, and ethical foundations behind these guidelines. They mark a landmark shift toward active harm reduction for adult smokers in the United States, weighing robust clinical trial evidence against complex public health values.

Why were new recommendations for e-cigarettes & smoking cessation needed?
#

Combustible tobacco remains the leading cause of preventable death in the U.S., claiming nearly 500,000 lives each year. Although over 68% of adult smokers wanted to quit in 2022 and more than half attempted to do so, fewer than 10% succeeded. This high failure rate highlights the need to broaden the clinical toolkit with alternative strategies.

How Australia has Lost Control of the Nicotine Market?

Sun, 30 Aug 2026 00:00:00 +0000

“When Best Practice Falls Short.” Australia has long been praised as a world leader in tobacco regulation, shaping global standards via plain packaging and strong public‑health initiatives. Yet this image hides a serious strategic misstep. By rigidly following WHO‑endorsed “best practice” measures—namely heavy excise taxes and a medical‑only framework for nicotine vapes—Australia has unintentionally sparked a sovereignty crisis. The government has effectively abandoned its duty to oversee the market, handing control over to criminal networks.

Nicotine Vapes and Smoking Cessation

Wed, 26 Aug 2026 00:00:00 +0000

Ten out of 100 smokers quit with nicotine e-cigarettes. Only six in 100 succeed with patches or gum. That is the headline finding of the latest Cochrane review — the most rigorous form of evidence synthesis in medicine — updated in August 2026 with data current to January 2026.

What the review examined
#

The Cochrane Collaboration maintains this as a ’living’ systematic review: researchers screen new trials monthly and update whenever relevant evidence appears. This update pooled 80 randomised controlled trials involving 29,861 adults who smoke — nine trials added since the previous version. The conclusions did not change. Randomised trials are the gold standard for answering whether a treatment works, and GRADE certainty ratings tell us how much to trust each result.

The Global Paradox

Mon, 24 Aug 2026 00:00:00 +0000

Why Cigarettes Are Everywhere But Non-Combustible Nicotine Alternatives Are Banned? Here’s something that should make you stop and think: In 2026, you can walk into almost any store worldwide and buy a pack of cigarettes - a product that kills up to half of its long-term users. But try to buy a vape or nicotine pouch to help quit smoking, and you might be breaking the law.

This is a global pattern that defies logic and costs lives.

The Swedish Miracle

Mon, 24 Aug 2026 00:00:00 +0000

Swedish males show lung cancer incidence below HALF the EU mean — harm reduction explains the gap.

Tobacco harm reduction finds its strongest national proof in Sweden, where measurable population health gains set a global benchmark. Lung cancer remains devastating across most of Europe, yet Swedish men experience strikingly low rates. Evidence ties this outcome to Sweden’s distinctive, multi-decade strategy built around snus.

The Stark Lung Cancer Gap
#

The figures speak plainly: Swedish male lung cancer incidence sits at 39 per 100,000 versus the EU average of 95 per 100,000 — under half the continental rate. This public health milestone translates to thousands of lives preserved annually.